| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/02/2004 | WO2004103381A1 Glycosaminoglycans for treatment emotional dysfunctions |
| 12/02/2004 | WO2004103380A1 Water-soluble isoflavone composition, process for producing the same, and use thereof |
| 12/02/2004 | WO2004103379A1 Salmeterol and ciclesonide combination |
| 12/02/2004 | WO2004103377A1 Use of compositions comprising an estrogenic component for the treatment and prevention of musculoskeletal pain |
| 12/02/2004 | WO2004103376A2 Skin treatments |
| 12/02/2004 | WO2004103375A1 Transfusion preparation for peripheral intravenous administration and method of stabilizing vitamin b1 |
| 12/02/2004 | WO2004103374A2 Imatinib combinations for head and neck cancers |
| 12/02/2004 | WO2004103373A1 Ophthalmic solution containing quinolone antimicrobial compound |
| 12/02/2004 | WO2004103372A1 Pharmaceutical compositions of varenicline |
| 12/02/2004 | WO2004103371A1 Use of cftr inhibitors for the treatment of chemotherapy-induced diarrhea |
| 12/02/2004 | WO2004103370A1 Method of treating atherosclerosis, dyslipidemias and related conditions and pharmaceutical compositions |
| 12/02/2004 | WO2004103368A1 Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity |
| 12/02/2004 | WO2004103367A1 Benzothiazole derivatives and use thereof in the treatment of diseases relates to the adenosine a2a receptor |
| 12/02/2004 | WO2004103365A1 Antiarthritic combinations |
| 12/02/2004 | WO2004103364A2 Treatment of respiratory disease by inhalation of synthetic matrix metalloprotease inhibitors |
| 12/02/2004 | WO2004103363A1 Use of poly-amminopyrrolecarboxamides alone or in combination with a cyclodextrin in the prophylaxis and treatment of animal parasitosis |
| 12/02/2004 | WO2004103362A1 Formulation of the total anhydrides of cantharidin for the treatment and prevention of severe acute respiratory syndrome infections and the preparation thereof |
| 12/02/2004 | WO2004103361A2 A pharmaceutical dosage form of citalopram |
| 12/02/2004 | WO2004103360A1 Compounds and preparaitons having antiviral effect |
| 12/02/2004 | WO2004103359A1 Pharmaceutical combination comprising modafinil and another drug |
| 12/02/2004 | WO2004103358A2 Combination of histone deacetylase inhibitors with chemotherapeutic agents |
| 12/02/2004 | WO2004103357A1 Compositions for the treatment of reduced blood flow |
| 12/02/2004 | WO2004103356A2 Treatment of emotional dysregulation |
| 12/02/2004 | WO2004103355A1 Method for augmenting the antitumor activity of anti-cancer agents |
| 12/02/2004 | WO2004103354A1 1´-acetoxychavicol acetate, enantiomers and derivatives thereof having anti-hiv activity |
| 12/02/2004 | WO2004103352A1 Ras antagonists for treating neurodegenerative disorders |
| 12/02/2004 | WO2004103350A1 Oral sustained release pharmaceutical composition |
| 12/02/2004 | WO2004103348A2 Solid particles comprising an anticonvulsant or an immunosuppressive coated with one or more surface modifiers |
| 12/02/2004 | WO2004103346A1 Pharmaceutical compositions of acitretin |
| 12/02/2004 | WO2004103344A1 Combination chemotherapy comprising a liposomal platinum complex |
| 12/02/2004 | WO2004103340A1 Water dispersible tablets of lamotrigine |
| 12/02/2004 | WO2004103311A2 Antibiotic composition |
| 12/02/2004 | WO2004103310A2 Methods and compositions for the treatment of metabolic disorders |
| 12/02/2004 | WO2004103309A2 Immunosuppressant compounds and compositions |
| 12/02/2004 | WO2004103307A2 Method of use of five and fifteen carbon fatty acids |
| 12/02/2004 | WO2004103306A2 Immunosuppressant compounds and compositions |
| 12/02/2004 | WO2004103305A2 Spiropyrazole compound |
| 12/02/2004 | WO2004103304A2 Treatment of t-cell mediated diseases |
| 12/02/2004 | WO2004103301A2 Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents |
| 12/02/2004 | WO2004103300A2 Compositions and methods of treating reduced blood flow to the cns with cox-2 inhibitors and cholinergic agents |
| 12/02/2004 | WO2004103299A2 Compositions and methods for the treatment of cns injuries |
| 12/02/2004 | WO2004103289A2 Driverse thyroid hormone receptor antagonists and uses thereof |
| 12/02/2004 | WO2004103286A2 Compositions of a cyclooxygenase-2 selective inhibitor and a cholimergic agent |
| 12/02/2004 | WO2004103284A2 Compositions of a benzenesulfonamide or methylsulfonylbenzene cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system |
| 12/02/2004 | WO2004103283A2 Compositions of a cyclooxygenase-2 selective inhibitor and a central nervous system stimulant for the treatment of central nervous system damage |
| 12/02/2004 | WO2004103280A2 Seaweed extract composition for treatment of diabetes and diabetic complications |
| 12/02/2004 | WO2004103278A2 Acyl sulfonamides as inhibitors of hiv integrase |
| 12/02/2004 | WO2004103276A2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/02/2004 | WO2004103274A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 12/02/2004 | WO2004103271A2 Disease prevention and vaccination prior to thymic reactivations |
| 12/02/2004 | WO2004103267A2 Methods to administer epothilone d |
| 12/02/2004 | WO2004103263A2 Dopamine and agonists and antagonists thereof for treatment of neurodegenerative diseases |
| 12/02/2004 | WO2004103260A2 Ternary and quaternary eutectic mixtures. |
| 12/02/2004 | WO2004103233A1 Compositions containing a combination of a pharmaceutical agent or a cosmetic agent and an oxy group-bearing aromatic aldehyde |
| 12/02/2004 | WO2004103154A2 Treatment of gastrointestinal dysfunction and related stress with an enantiomerically-pure (r) 2,3-benzodiazepine |
| 12/02/2004 | WO2004103057A2 Compositions and methods for inducing adipose tissue cell death |
| 12/02/2004 | WO2004093867A3 Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use |
| 12/02/2004 | WO2004089281A3 Novel polymorphs of tolterodine tartrate |
| 12/02/2004 | WO2004085582A3 Lipid-improving agent and composition containing lipid-improving agent |
| 12/02/2004 | WO2004084895A3 Modulation of cell death |
| 12/02/2004 | WO2004083364A3 Cell preparation and use of the preparation for treating joints and cartilage defects, and methods for the production thereof |
| 12/02/2004 | WO2004083172A3 Process for the preparation of 7-amino (p-hydroxyphenylglyclyamido) cephem compounds |
| 12/02/2004 | WO2004082624A3 Modafinil-based neurorehabilitation of impaired neurological function associated with injury |
| 12/02/2004 | WO2004082587A3 Stable lamotrigine pharmaceutical compositions and processes for their preparation |
| 12/02/2004 | WO2004082454A3 Endovascular implant with an at least sectional active coating made of radjadone and/or a ratjadone derivative |
| 12/02/2004 | WO2004080396A3 Liposomal curcumin for treatment of cancer |
| 12/02/2004 | WO2004080393A3 Selective cytokine inhibitory drugs for treating disorders of the central nervous system |
| 12/02/2004 | WO2004078746A3 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatrory disorders |
| 12/02/2004 | WO2004078129A3 Method for decreasing low density lipoprotein |
| 12/02/2004 | WO2004075849A3 Method and composition for treating hypopigmentation of the hair and skin |
| 12/02/2004 | WO2004073653A8 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same |
| 12/02/2004 | WO2004073635A3 Compositions comprising a plurality of particles or agglomerates having a defined particle size |
| 12/02/2004 | WO2004071466A3 Manufacturing process for liposomal preparations |
| 12/02/2004 | WO2004071431A3 Method and composition for treating neurodegenerative disorders |
| 12/02/2004 | WO2004071156A3 Use of edible acid in fast-dispersing pharmaceutical solid dosage forms |
| 12/02/2004 | WO2004069840A3 Production of tetrahydroquinoline benzofurans |
| 12/02/2004 | WO2004069161A3 Polycosanols from ericerus pela wax |
| 12/02/2004 | WO2004066962A3 Method of treatment of prostate cancer and composition for treatment thereof |
| 12/02/2004 | WO2004066952A3 Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases |
| 12/02/2004 | WO2004064779A3 Use of nitroglycerin to relieve nocturnal muscle cramps |
| 12/02/2004 | WO2004060321A3 Cardioprotective delta opioid receptor agonists and methods of using same |
| 12/02/2004 | WO2004058141A3 An agent for controlling bcl-2 expression comprising ginsenoside f1 as an active component |
| 12/02/2004 | WO2004050027A3 Materials and methods for treating ocular-related disorders |
| 12/02/2004 | WO2004044144A3 Methods for inducing regeneration, remyelination, and hypermyelination of nervous tissue |
| 12/02/2004 | WO2004041198A3 Heat pasteurized liquids containing glucosamine |
| 12/02/2004 | WO2004041191A3 Methods for the treatment, prevention and management of macular degeneration |
| 12/02/2004 | WO2004034993A3 Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor |
| 12/02/2004 | WO2004032825A3 Use of 2,3 alkylcarbonyloxybenzoic acids in the treatment of anthrax |
| 12/02/2004 | WO2004028448A9 Method of alleviating pain via inhibition of neurotransmitter synthesis |
| 12/02/2004 | WO2004027020A3 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 12/02/2004 | WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors |
| 12/02/2004 | WO2004024074A3 Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators |
| 12/02/2004 | WO2004017897A3 Aripiprazole complex formulation and method |
| 12/02/2004 | WO2004010952A3 Methods and compositions for treatment of dermal conditions |
| 12/02/2004 | WO2003104256A3 THE CaR RECEPTOR AS A MEDIATOR OF MIGRATORY CELL CHEMOTAXIS AND/OR CHEMOKINESIS |
| 12/02/2004 | WO2003095667A3 Autoimmune conditions and nadph oxidase defects |
| 12/02/2004 | WO2003085377A3 Novel pancortin-pablo protein interactions and methods of use thereof |
| 12/02/2004 | WO2003064387A3 Substituted indoles as alpha-1 agonists |
| 12/02/2004 | WO2003039452A3 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
| 12/02/2004 | WO2003025119A3 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies |